HEADER GALACTOSIDE-BINDING LECTIN 01-APR-22 7XFA TITLE STRUCTURE OF HUMAN GALECTIN-3 CRD IN COMPLEX WITH MONOSACCHARIDE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GAL-3,35 KDA LECTIN,CARBOHYDRATE-BINDING PROTEIN 35,CBP 35, COMPND 5 GALACTOSE-SPECIFIC LECTIN 3,GALACTOSIDE-BINDING PROTEIN,GALBP,IGE- COMPND 6 BINDING PROTEIN,L-31,LAMININ-BINDING PROTEIN,LECTIN L-29,MAC-2 COMPND 7 ANTIGEN; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGALS3, MAC2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS LECTIN, GALACTOSE, FIBROSIS, SUGAR BINDING PROTEIN, GALACTOSIDE- KEYWDS 2 BINDING LECTIN EXPDTA X-RAY DIFFRACTION AUTHOR J.SHUKLA,S.RAMAN,K.GHOSH REVDAT 2 29-NOV-23 7XFA 1 REMARK REVDAT 1 12-OCT-22 7XFA 0 JRNL AUTH C.LIU,P.R.JALAGAM,J.FENG,W.WANG,T.RAJA,M.R.SURA, JRNL AUTH 2 R.K.V.L.P.MANEPALLI,B.R.ALIPHEDI,S.MEDAVARAPU,S.K.NAIR, JRNL AUTH 3 V.MUTHALAGU,R.NATESAN,A.GUPTA,B.BENO,M.PANDA,K.GHOSH, JRNL AUTH 4 J.K.SHUKLA,H.SALE,P.HALDAR,N.KALIDINDI,D.SHAH,D.PATEL, JRNL AUTH 5 A.MATHUR,B.A.ELLSWORTH,D.CHENG,A.REGUEIRO-REN JRNL TITL IDENTIFICATION OF MONOSACCHARIDE DERIVATIVES AS POTENT, JRNL TITL 2 SELECTIVE, AND ORALLY BIOAVAILABLE INHIBITORS OF HUMAN AND JRNL TITL 3 MOUSE GALECTIN-3. JRNL REF J.MED.CHEM. V. 65 11084 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35969688 JRNL DOI 10.1021/ACS.JMEDCHEM.2C00517 REMARK 2 REMARK 2 RESOLUTION. 0.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 0.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 75738 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.710 REMARK 3 FREE R VALUE TEST SET COUNT : 3564 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 0.98 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.00 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.47 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3832 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.3178 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3650 REMARK 3 BIN R VALUE (WORKING SET) : 0.3174 REMARK 3 BIN FREE R VALUE : 0.3242 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.75 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 182 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1108 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 239 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.30540 REMARK 3 B22 (A**2) : 0.93070 REMARK 3 B33 (A**2) : 0.37470 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.122 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.029 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.030 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.027 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.028 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1277 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 1774 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 462 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 35 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 197 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1277 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 164 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1572 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.17 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 5.80 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 13.31 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7XFA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-APR-22. REMARK 100 THE DEPOSITION ID IS D_1300028687. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 75866 REMARK 200 RESOLUTION RANGE HIGH (A) : 0.980 REMARK 200 RESOLUTION RANGE LOW (A) : 36.830 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 0.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.01 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 7CXA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.06 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 28-35% PEG 4000/6000, 0.1M TRIS (PH REMARK 280 7.5 - PH 8.5), 0.1M MGCL2, 0.4M NASCN, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.41200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.55900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.09350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.55900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.41200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.09350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 86 REMARK 465 GLY A 87 REMARK 465 SER A 88 REMARK 465 SER A 89 REMARK 465 HIS A 90 REMARK 465 HIS A 91 REMARK 465 HIS A 92 REMARK 465 HIS A 93 REMARK 465 HIS A 94 REMARK 465 HIS A 95 REMARK 465 SER A 96 REMARK 465 SER A 97 REMARK 465 GLY A 98 REMARK 465 GLU A 99 REMARK 465 THR A 100 REMARK 465 VAL A 101 REMARK 465 ARG A 102 REMARK 465 PHE A 103 REMARK 465 GLN A 104 REMARK 465 GLY A 105 REMARK 465 HIS A 106 REMARK 465 MET A 107 REMARK 465 GLY A 108 REMARK 465 ALA A 109 REMARK 465 PRO A 110 REMARK 465 ALA A 111 REMARK 465 GLY A 112 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 129 -3.69 88.89 REMARK 500 ASN A 164 75.58 -151.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 638 DISTANCE = 6.15 ANGSTROMS REMARK 525 HOH A 639 DISTANCE = 7.35 ANGSTROMS DBREF 7XFA A 108 250 UNP P17931 LEG3_HUMAN 108 250 SEQADV 7XFA MET A 86 UNP P17931 INITIATING METHIONINE SEQADV 7XFA GLY A 87 UNP P17931 EXPRESSION TAG SEQADV 7XFA SER A 88 UNP P17931 EXPRESSION TAG SEQADV 7XFA SER A 89 UNP P17931 EXPRESSION TAG SEQADV 7XFA HIS A 90 UNP P17931 EXPRESSION TAG SEQADV 7XFA HIS A 91 UNP P17931 EXPRESSION TAG SEQADV 7XFA HIS A 92 UNP P17931 EXPRESSION TAG SEQADV 7XFA HIS A 93 UNP P17931 EXPRESSION TAG SEQADV 7XFA HIS A 94 UNP P17931 EXPRESSION TAG SEQADV 7XFA HIS A 95 UNP P17931 EXPRESSION TAG SEQADV 7XFA SER A 96 UNP P17931 EXPRESSION TAG SEQADV 7XFA SER A 97 UNP P17931 EXPRESSION TAG SEQADV 7XFA GLY A 98 UNP P17931 EXPRESSION TAG SEQADV 7XFA GLU A 99 UNP P17931 EXPRESSION TAG SEQADV 7XFA THR A 100 UNP P17931 EXPRESSION TAG SEQADV 7XFA VAL A 101 UNP P17931 EXPRESSION TAG SEQADV 7XFA ARG A 102 UNP P17931 EXPRESSION TAG SEQADV 7XFA PHE A 103 UNP P17931 EXPRESSION TAG SEQADV 7XFA GLN A 104 UNP P17931 EXPRESSION TAG SEQADV 7XFA GLY A 105 UNP P17931 EXPRESSION TAG SEQADV 7XFA HIS A 106 UNP P17931 EXPRESSION TAG SEQADV 7XFA MET A 107 UNP P17931 EXPRESSION TAG SEQRES 1 A 165 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 165 GLU THR VAL ARG PHE GLN GLY HIS MET GLY ALA PRO ALA SEQRES 3 A 165 GLY PRO LEU ILE VAL PRO TYR ASN LEU PRO LEU PRO GLY SEQRES 4 A 165 GLY VAL VAL PRO ARG MET LEU ILE THR ILE LEU GLY THR SEQRES 5 A 165 VAL LYS PRO ASN ALA ASN ARG ILE ALA LEU ASP PHE GLN SEQRES 6 A 165 ARG GLY ASN ASP VAL ALA PHE HIS PHE ASN PRO ARG PHE SEQRES 7 A 165 ASN GLU ASN ASN ARG ARG VAL ILE VAL CYS ASN THR LYS SEQRES 8 A 165 LEU ASP ASN ASN TRP GLY ARG GLU GLU ARG GLN SER VAL SEQRES 9 A 165 PHE PRO PHE GLU SER GLY LYS PRO PHE LYS ILE GLN VAL SEQRES 10 A 165 LEU VAL GLU PRO ASP HIS PHE LYS VAL ALA VAL ASN ASP SEQRES 11 A 165 ALA HIS LEU LEU GLN TYR ASN HIS ARG VAL LYS LYS LEU SEQRES 12 A 165 ASN GLU ILE SER LYS LEU GLY ILE SER GLY ASP ILE ASP SEQRES 13 A 165 LEU THR SER ALA SER TYR THR MET ILE HET D9J A 301 60 HETNAM D9J (2~{S},3~{R},4~{R},5~{R},6~{R})-4-[4-[4-CHLORANYL-3,5- HETNAM 2 D9J BIS(FLUORANYL)PHENYL]-1,2,3-TRIAZOL-1-YL]-2-[2-[5- HETNAM 3 D9J CHLORANYL-2-(TRIFLUOROMETHYL)PHENYL]-5-METHYL-1,2,4- HETNAM 4 D9J TRIAZOL-3-YL]-6-(HYDROXYMETHYL)OXANE-3,5-DIOL FORMUL 2 D9J C24 H19 CL2 F5 N6 O4 FORMUL 3 HOH *239(H2 O) HELIX 1 AA1 LYS A 227 ILE A 231 5 5 SHEET 1 AA1 6 TYR A 118 PRO A 121 0 SHEET 2 AA1 6 LYS A 233 GLY A 238 -1 O LEU A 234 N LEU A 120 SHEET 3 AA1 6 ILE A 145 ARG A 151 -1 N ALA A 146 O SER A 237 SHEET 4 AA1 6 ASP A 154 GLU A 165 -1 O PHE A 157 N PHE A 149 SHEET 5 AA1 6 ARG A 168 LEU A 177 -1 O ARG A 168 N GLU A 165 SHEET 6 AA1 6 ASN A 180 TRP A 181 -1 O ASN A 180 N LEU A 177 SHEET 1 AA2 6 TYR A 118 PRO A 121 0 SHEET 2 AA2 6 LYS A 233 GLY A 238 -1 O LEU A 234 N LEU A 120 SHEET 3 AA2 6 ILE A 145 ARG A 151 -1 N ALA A 146 O SER A 237 SHEET 4 AA2 6 ASP A 154 GLU A 165 -1 O PHE A 157 N PHE A 149 SHEET 5 AA2 6 ARG A 168 LEU A 177 -1 O ARG A 168 N GLU A 165 SHEET 6 AA2 6 GLU A 185 GLN A 187 -1 O GLU A 185 N CYS A 173 SHEET 1 AA3 5 ALA A 216 ASN A 222 0 SHEET 2 AA3 5 HIS A 208 VAL A 213 -1 N VAL A 211 O LEU A 218 SHEET 3 AA3 5 PRO A 197 VAL A 204 -1 N LEU A 203 O LYS A 210 SHEET 4 AA3 5 MET A 130 VAL A 138 -1 N ILE A 132 O VAL A 202 SHEET 5 AA3 5 ILE A 240 MET A 249 -1 O THR A 248 N LEU A 131 CISPEP 1 VAL A 116 PRO A 117 0 1.11 CRYST1 36.824 58.187 63.118 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027156 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017186 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015843 0.00000